•  
  •  
  •  
  •  

2026-07-25 06:28:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%

Keywords Selected:  FormulationFacility

Stock Report

  • Concord Biotech Ltd successfully completes PPB and NDA inspection
  • Alembic Pharmaceuticals Ltd's Oncology facility successfully completes USFDA inspection
  • US FDA inspection at Alembic Pharmaceuticals Limited' Oral Solid Formulation Facility at Panelav
  • Unichem Laboratories Ltd gets 5 observations from USFDA for Goa formulation facility
  • Alembic Pharmaceuticals Limited receives EIR from USFDA for Oncology Formulation facility
  • APL Healthcare Ltd updates on inspection
  • Concord Biotech Ltd receives GMP certificate from Kenya regulator
  • Zydus receives EIR for the formulation manufacturing facility at SEZ 2, Ahmedabad
  • USFDA inspects Ajanta Pharma Ltd's Formulation facility at Dahej
  • USFDA completes inspection of Natco's Vizag Formulation facility
  • USFDA inspection at Indoco Remedies Limited's Solid Oral Formulation Facility - Plant 1 at Goa
  • USFDA inspects Alembic Pharmaceuticals' Oncology Injectable Formulation Facility at Panelav
  • Ajanta Pharma Ltd gets Form 483 with 2 procedural observations for Dahej Formulation facility
  • Strides announces successful completion of US FDA inspection at its Singapore facility
  • USFDA issues Form 483 for Glenmark Pharmaceuticals Ltd's Aurangabad facility

Latest Post

  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025